novo nordisk glp 1 drug Novo's Wegovy becomes first GLP-1 approved for MASH Article » PBD

Our renewed push to develop oral therapies came directly after a high-profile failure more than a decade ago when we attempted to develop an inhaled form of insulin

doi: 10.1136/ard-2023-224762 111 AthanassiouPAthanassiouL

Incorporate SPF into your daily routine, even indoors

Research suggests combining copper peptide serums with microneedling significantly enhances delivery to the dermal papilla cells

Chronic activation of astrocytes and microglia leads to the release of cytokines involved in inflammation, chemokines, and other inflammatory mediators

The biggest phase 3 clinical trial showed a 28.7% reduction in weight in participants with obesity or overweight